Thought Leadership Event Will Focus on the Ways in Which Artificial Intelligence Will Impact the Healthcare and Pharmaceutical Industries
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) — Although the benefits of innovative and general-purpose technologies often promise to create sweeping changes across numerous sectors, realizing their full potential beyond the hype requires careful navigation and implementation. The rise of AI in the realm of healthcare is a prime example of technology that is brimming with possibilities—from improving diagnostics to personalizing patient care—but it must go way beyond mere technological advancement in order to be successful. Those developing and implementing AI for the healthcare industry need to have a deep understanding of its practical application and integration, which involves not only embracing AI’s capabilities but also comprehending the nuances and complexities of the healthcare systems where it is to be deployed. The ultimate indicator of how successful AI will be in a healthcare setting hinges on synergizing technological innovation with institutional readiness that will ensure AI’s deployment in healthcare is both effective and transformative.
The Fordham University Gabelli School of Business Global Healthcare Innovation Management Center (GHIMC) has invited thought leaders and innovators from academia, as well as those working in AI and the healthcare/pharmaceutical industries to examine the depth and complexity of the issues facing researchers, entrepreneurs, and executives at this critical juncture in the development of AI. Panelists will explore and debate critical topics including AI’s role in revolutionizing drug discovery in the pharmaceutical industry and in clinical trials; advancements in computational pathology and AI’s future in healthcare diagnostics; as well as the commercialization of AI and the challenges it poses.
This in-person event will take place on February 1, 2024, 9:00am – 3:20pm on the 12th Floor of the Lowenstein Building, 113 W. 60 Street at Fordham University’s Lincoln Center campus. It is free and open to the public.
Food and beverages will be served.
Members of the press, click here to register
Members of the general public, please register here: https://bit.ly/41SHiPk
Panelists will include:
Dr. Roy Baynes, MMed, Ph.D., executive vice president and chief medical officer, Eikon Therapeutics
Amol M. Joshi, Ph.D., Bern Beatty Fellow and associate professor of strategic management, Wake Forest University (WFU) School of Business
Thomas J. Fuchs, Ph.D., co-director of the Hasso Plattner Institute for Digital Health at Mount Sinai, dean of artificial intelligence and human health, and professor of computational pathology and computer science, Icahn School of Medicine at Mount Sinai
Andree Bates, Ph.D., founder, Eularis
Marc Paradis, vice president of data strategy, Northwell Holdings.
The panels will be moderated by Falguni Sen, Ph.D., director of the Global Healthcare Innovation Management Center, and professor of Strategy and Statistics, Gabelli School of Business; and Navid Asgari, Ph.D., associate professor of Strategy and Statistics, Gabelli School of Business.
About the Global Healthcare Innovation Management Center (GHIMC)
The mission of the Global Healthcare Innovation Management Center is to provide greater affordability and access to healthcare through an efficient management of the global innovation process in healthcare systems, resulting in a reduction of disease burdens and creation of healthier lives. It aims to achieve this through independent research, training and creating a platform where multi-stakeholder dialogue and discourse is made possible. Its goals include: developing case studies of innovations occurring globally in the field of healthcare; conducting research in different management aspects, which affect the outcome of such innovations; and delivering educational programs to managers in different aspects of the management of healthcare innovations. The Center also provides a forum for a creative dialogue among global policy makers, thought leaders, and academics through workshops and seminars.
About Fordham University’s Gabelli School of Business
Founded in 1920, the mission of Fordham University’s Gabelli School of Business is to inspire and empower positive global change, developing students into compassionate business leaders and supporting faculty members and students in the ongoing generation of new knowledge. The Gabelli School has become a driver of social innovation by equipping graduates to be business leaders who understand and meet the need for sustainability in business and who are able to harness the power of social responsibility for both financial success and societal impact. Through its many graduate and undergraduate degree programs and a diverse range of faculty research initiatives, the Gabelli School of Business works collectively to redesign business as a sustainable force for prosperity.
CONTACT: Michelle Miller Fordham University Gabelli School of Business 2126366761 mmiller201@fordham.edu Paola Curcio-Kleinman Fordham University Gabelli School of Business 2126366311 pcurciokleinman@fordham.edu
- Primega Group Holdings Limited Announces Ticker Symbol Change to ZDAI - May 14, 2025
- Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2025 Fourth Quarter and Year End Earnings Release and Conference Call Webcast - May 14, 2025
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ibotta, NET Power, Zenas BioPharma, and BigBear and Encourages Investors to Contact the Firm - May 14, 2025
